• Fragmented stakeholder landscape (providers, payers, patients, regulators) makes clear positioning difficult and slows adoption.
• Regulatory and compliance complexity (HIPAA, FDA, CMS, FTC) creates risk-averse buyers and stalls procurement.
• Trust deficit from unsubstantiated claims; clinicians and administrators demand evidence and economic outcomes.
✓ Qualified inbound opportunities increase 30–70% within 6–12 months as the book drives discovery and referrals.
✓ Win rates improve 15–25% and sales cycles shorten 10–20% via clearer problem framing and consensus-building tools.
✓ Average contract value grows 12–30% after establishing category leadership and executive trust.